BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

  April 27, 2026

   · 

  3 min read
• Press Releases

  Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

  April 27, 2026

   · 

  5 min read
• Press Releases

  ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026

  April 27, 2026

   · 

  4 min read
• Press Releases

  BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET

  April 27, 2026

   · 

  1 min read
• Press Releases

  Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem

  April 27, 2026

   · 

  2 min read
• Press Releases

  CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

  April 27, 2026

   · 

  7 min read
• Press Releases

  Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty

  April 27, 2026

   · 

  10 min read
• Press Releases

  Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

  April 27, 2026

   · 

  11 min read
• Press Releases

  BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease ahead of Topline Data in 2Q26, on May 7, 2026

  April 27, 2026

   · 

  5 min read
• Press Releases

  HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors

  April 27, 2026

   · 

  4 min read